Evaluation of anti-D Reagents as Rh (D) Blood Typing
Keywords:
Anti-D, Rh (D) typingAbstract
Abstract : A total of eleven anti-D reagents, from commercial and one from the National Blood Centre, Thai Red Cross Society (NBC, TRCS) were evaluated for their efficacy as Rh/D) blood typing reagents. They were tested for potency, avidity, specicity and ability to detect weak Dantigens, as well as DVI cells. It was found that all anti-D sera were exceeded the potency and avidity requirements of WHO standard by having a titer of greater than 1:64 with Rir cells and giving positve result within suxty second of muxing in manual slide test. Most of them were capable of detecting 20 samples of weak D antigen. For the seven samples of DVI cells, two commercial anti-D sera were unable to detect any of them where as another two commercial anti-D sera detect these cells by direct agglutination. The other six commercial and the NBC TROS anti-D sera were able to detect DVI cells by indirect antigiobulin test (IAT). In conchusion, the ant-D reagents from various companies ditered in efficacy for detection of weak Dand D VI cells. Furthermore some of these cells could be typed as Rh(D) positive by one reagent and as Rh(D) negative by another reagent. Evaluation of anti-D reagent is essentual in selecting appropriate reagent that can be used for both donor and patient Rh(D) typing.
Downloads
References
Levine P, Stetson RE. An unusual case of intragroup agglutination. JAMA 1939;113:126-7.
Stration F. A new allelomorph. London : Nature 1946;158:25-6.
Argall CI, Ball JM, Trentelman E. Presence of an anti-D antibody in the serum of Du patient. J Lab Clin Med 1953;41:495-8.
Weiner As, Unger LJ. Rh factors related to the Rho factor as a source of clinical problem. JAMA 1959;169:696-9.
Technical Manual. 12" ed Virginia : Vengelen-Tyier. Am Asso Blood Banks 1996;255-74.
Thompson KM, Tolliday B, Hamblin L and Hughes-Jones NC. The production of Human Monoclonal Antibodies against the D antigen of the Rh system. Biotest Bulletin 1989;4:19-22.
McCann MC, James K, Kumpel BM. Production and use of human monoclonal anti-D antibodies. Immunol Methods 1988;115:3-15.
Van Rhenen DJ, Thijssen PMHJ, Overbeeke MAM. Testing efficacy of anti-D sera by a panel of donor red cells with weak reacting D antigen and with partial D antigens. Vox Sang 1989;56:274-7.
ศศิธร เพชรจันทร, จริยา สายพิณ, กาญจนา เอื้อตระกูลพูนสุข. ทัศน์ยานี จันทนยิ่งยง. Detection of weak D Antigen by Monoclonal and Polyclonal Anti-D. วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต 1994;4:127-34.
Lomas C, Mc Coll K, Tippett P. Further complexities of the Rh antigen D disclosed by testing category DII cells with monoclonal anti-D. Transf Med 1993;3:67-9.
Loma C, Tippett P, Thompson KM, Melamed MD, Hughes-Jones NC. Demonstration of seven epitopes on the Rh antigen D using human monoclonal anti-D antibodies and red cells from D categories. Vox Sang 1989;57:261-4.
Tippett P. Sub-divisions of the Rh (D) antigen. Med Lab Sci 1988;45:88-93.
Chester MA, Johnson U, Lundblad A. Low B, Messeter L, Samuelson B. Proceedings of the Second International Workshop and Symposium on Monoclonal Antibodies against Human Red Blood cell and Related Antigens Lund, 1990.
Technical Manual 12* ed. Virginia : Vengelen-Tyler. Am Asso Blood Banks 1996;607.
Sonneborn HH. Monoclonal antibodies for Rh-typing including the determination of D variants. Clin Lab 1996;1+2:57-8.
Jones JW, Voak D, Scott ML, Sonneborn HH. Policies for the selection of Rh D typing reagents. Biotest Bulletin 1997;5:485-94.
Stroup M. Controversies in Transfusion medicine. D" testing : Pro Transfusion 1991;3:273-6.
Mayne K, Bowell P, Woodward T, Sibley C, Lomas C, Tippett P. Rh immunization by the partial D antigen of category Dva. Br J Haematol 1990;76:537-9.
World Health Organization CBS. Publishers & Distribution. The Rh blood Group System in Safe Blood and Blood Product, Module 3, Blood group Serology. 1995:38.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.